Regarding the role of galectin-9 in esophageal cancer, Hou and coworkers analyzed the expression of galectin-9 and its binding partner Tim-3 in tumor tissues obtained from 45 ESCC patients during curative surgical resection. The gene discussed is LGALS9; the disease is esophageal squamous cell carcinoma.